Filed: 5/15/2025ACC: 0000950123-25-005509
📋 What this filing means
OMEGA FUND MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 13 equity positions with a total reported market value of $169.46M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
13
Positions
$169.46M
Total AUM (reported)
30.64M
Total Shares
Allocation by class
COMMON STOCK$146.26M86.3%
COMMON STOCK CLASS A$23.01M13.6%
WARRANT$192.9K0.1%
Portfolio Concentration
Top 3$97.82M57.7%
4–10$68.09M40.2%
11–25$3.56M2.1%
Top 3 weight
57.7%
Top 10 weight
97.9%
Voting Authority Distribution
Total shares with voting rights: 30.64M
Sole
Full voting authority
30.64M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole13
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings13
Rows:
Kestra Med Technologies Ltd.
SOLEShares1.80M
TypeSH
Market value$44.75M
26.41%
Sole
1.80M
Shared
0.00
None
0.00
Bicara Therapeutics Inc.
SOLEShares2.20M
TypeSH
Market value$28.73M
16.95%
Sole
2.20M
Shared
0.00
None
0.00
Beta Bionics Inc.
SOLEShares1.99M
TypeSH
Market value$24.34M
14.36%
Sole
1.99M
Shared
0.00
None
0.00
Nuvation Bio
SOLEShares13.07M
TypeSH
Market value$23.01M
13.58%
Sole
13.07M
Shared
0.00
None
0.00
Replimune Group
SOLEShares1.98M
TypeSH
Market value$19.26M
11.36%
Sole
1.98M
Shared
0.00
None
0.00
Upstream Bio Inc.
SOLEShares2.04M
TypeSH
Market value$12.46M
7.35%
Sole
2.04M
Shared
0.00
None
0.00
Lexeo Therapeutics
SOLEShares1.18M
TypeSH
Market value$4.11M
2.43%
Sole
1.18M
Shared
0.00
None
0.00
Alumis Inc.
SOLEShares653.22K
TypeSH
Market value$4.01M
2.37%
Sole
653.22K
Shared
0.00
None
0.00
Ikena Oncology
SOLEShares2.25M
TypeSH
Market value$2.88M
1.70%
Sole
2.25M
Shared
0.00
None
0.00
enGene Holdings Inc.
SOLEShares526.36K
TypeSH
Market value$2.36M
1.39%
Sole
526.36K
Shared
0.00
None
0.00
Immunic Inc.
SOLEShares1.79M
TypeSH
Market value$1.95M
1.15%
Sole
1.79M
Shared
0.00
None
0.00
Sana Biotechnology, Inc.
SOLEShares843.75K
TypeSH
Market value$1.42M
0.84%
Sole
843.75K
Shared
0.00
None
0.00
enGene Holdings Inc.
SOLEShares321.50K
TypeSH
Market value$192.9K
0.11%
Sole
321.50K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Kestra Med Technologies Ltd.SOLE | Common Stock | 1.80M | SH | $44.75M 26.41% | 1.80M | 0.00 | 0.00 |
Bicara Therapeutics Inc.SOLE | Common Stock | 2.20M | SH | $28.73M 16.95% | 2.20M | 0.00 | 0.00 |
Beta Bionics Inc.SOLE | Common Stock | 1.99M | SH | $24.34M 14.36% | 1.99M | 0.00 | 0.00 |
Nuvation BioSOLE | Common Stock Class A | 13.07M | SH | $23.01M 13.58% | 13.07M | 0.00 | 0.00 |
Replimune GroupSOLE | Common Stock | 1.98M | SH | $19.26M 11.36% | 1.98M | 0.00 | 0.00 |
Upstream Bio Inc.SOLE | Common Stock | 2.04M | SH | $12.46M 7.35% | 2.04M | 0.00 | 0.00 |
Lexeo TherapeuticsSOLE | Common Stock | 1.18M | SH | $4.11M 2.43% | 1.18M | 0.00 | 0.00 |
Alumis Inc.SOLE | Common Stock | 653.22K | SH | $4.01M 2.37% | 653.22K | 0.00 | 0.00 |
Ikena OncologySOLE | Common Stock | 2.25M | SH | $2.88M 1.70% | 2.25M | 0.00 | 0.00 |
enGene Holdings Inc.SOLE | Common Stock | 526.36K | SH | $2.36M 1.39% | 526.36K | 0.00 | 0.00 |
Immunic Inc.SOLE | Common Stock | 1.79M | SH | $1.95M 1.15% | 1.79M | 0.00 | 0.00 |
Sana Biotechnology, Inc.SOLE | Common Stock | 843.75K | SH | $1.42M 0.84% | 843.75K | 0.00 | 0.00 |
enGene Holdings Inc.SOLE | Warrant | 321.50K | SH | $192.9K 0.11% | 321.50K | 0.00 | 0.00 |